AJ Biologics agrees to acquire SSI vaccine production business from theDanish state

AJ Pharma makes its first acquisition in Denmark, creating an independent entity from the state-owned SSI vaccine production business through its subsidiary, AJ Biologics.
This will open new avenues for growth and employment for the Danish business and expand at a global level

Mrs Pia Lading, Executive Vice President of Statens Serum Institut, Dr Pierre Morgon

Seated, left to right : Klaus Hermansen, CEO AJ Vaccines, Mustafa Farooki, CFO Aljomiah, Sheik Abdulaziz Aljomiah, Chairman Akjomiah, Dr Tabassum Khan, Chairman AJ Vaccines, Dr Mads Melbye, CEO Statens Serum Institute. Standing, left to right : Dr Pierre Morgon, Advisor to the CEO and to the Chairman, Monica Reib, Partner Bech-Bruun, Selvam Ramaraj, Director AJ Pharma Holding.

Read More